Transamerica Financial Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-13
Closed -$2K 443
2016
Q4
$2K Sell
13
-12
-48% -$952 ﹤0.01% 318
2016
Q3
$2K Sell
25
-4
-14% -$323 ﹤0.01% 331
2016
Q2
$3K Sell
29
-6,038
-100% -$431K ﹤0.01% 276
2016
Q1
$334K Buy
6,067
+3,360
+124% +$183K 0.03% 262
2015
Q4
$168K Buy
2,707
+160
+6% +$10.1K 0.01% 310
2015
Q3
$161K Sell
2,547
-69
-3% -$4.92K 0.01% 295
2015
Q2
$192K Buy
2,616
+116
+5% +$8.38K 0.01% 332
2015
Q1
$164K Buy
2,500
+2,431
+3,523% +$162K 0.01% 342
2014
Q4
$5K Buy
69
+52
+306% +$3.35K ﹤0.01% 560
2014
Q3
$1K Hold
17
﹤0.01% 675
2014
Q2
$2K Hold
17
﹤0.01% 591
2014
Q1
$2K Sell
17
-60
-78% -$3.91K ﹤0.01% 558
2013
Q4
$5K Sell
77
-15,021
-99% -$870K ﹤0.01% 506
2013
Q3
$810K Buy
15,098
+3,504
+30% +$180K 0.11% 113
2013
Q2
$530K Buy
+11,594
New +$502K 0.09% 114

Other funds holding STJ

Transamerica Financial Advisors's STJ Position: Q1 2017 in Review

Transamerica Financial Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 13 shares — an estimated $2K sold.

Transamerica Financial Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $810K in Q3 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Transamerica Financial Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Transamerica Financial Advisors sold 13 St Jude Medical shares in Q1 2017, an estimated $2K.
  • Transamerica Financial Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Transamerica Financial Advisors's St Jude Medical position peaked at $810K in Q3 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Transamerica Financial Advisors's 13F filing for Q1 2017, filed 10 May 2017.